Articles From: LoJack Reports Financial Results for the Third Quarter of 2014; Appoints New Chief Financial Officer to Auspex Pharmaceuticals Initiates Second Pivotal Clinical Trial for SD-809 in Tardive Dyskinesia


Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, is committed to connecting emergency clinicians to technology in a way that improves clinical practice and patient outcomes.
Sign-up for Teleflex to Introduce Innovative Portfolio at EMS World Expo 2014 investment picks
http://media.marketwire.com/attachments/201410/80742_274134_RR_MEDIA_LOCKUP_NEGATIVE_RGB288x442.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155151&ProfileId=051205&sourceType=1 LONDON, UNITED KINGDOM --
Sign-up for RR Media Triumph at TVB Europe Awards investment picks
MOUNTAIN VIEW, Calif., Oct.
Sign-up for VIVUS Announces Date of Third Quarter 2014 Update and Financial Results Conference Call investment picks
Harman International Industries, Incorporated (NYSE:HAR), the premier audio, visual, infotainment and enterprise automation group, today announced results for the first quarter ended September 30, 2014.
Sign-up for HARMAN Reports First Quarter Fiscal Year 2015 Results investment picks
Harman International Industries, Incorporated (NYSE:HAR) declared a cash dividend on October 30, 2014 of $0.33 cents per share for the quarter ended September 30, 2014.
Sign-up for HARMAN Announces Quarterly Cash Dividend investment picks
Harman International Industries, Incorporated (NYSE:HAR), today announced that its Board of Directors has authorized the repurchase of up to $500 million of the Company's common stock over the next three years.
Sign-up for HARMAN Board of Directors Authorizes $500M, Three Year Share Buyback Program investment picks
ATK Second Quarter Year-Over-Year Sales Increased 11 percent ATK Second Quarter Year-Over-Year Operating Profit Increased 8 percent ATK Second Quarter Year-Over-Year EPS Increased 4 percent ATK Updates its FY15 Sales Guidance and Reaffirms its FY15 EPS and Free Cash Flow Guidance ARLINGTON, Va.
Sign-up for ATK Reports FY15 Second Quarter Operating Results investment picks
20% Growth Results in Record U.S. Feraheme Sales Lumara Health Acquisition on Track to Close in Fourth Quarter WALTHAM, Mass., Oct.
Sign-up for AMAG Pharmaceuticals Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2014 investment picks
AstraZeneca (NYSE:AZN) today announced that the U.S. Food and Drug Administration has approved once-daily XIGDUO™ XR (dapagliflozin and metformin hydrochloride extended-release) for the treatment of adults with type 2 diabetes.
Sign-up for U.S. FDA Approves Once-Daily XIGDUO™ XR Tablets for Adults with Type 2 Diabetes investment picks
CANONSBURG, Pa.
Sign-up for CONE Midstream Reports Third Quarter Results investment picks
hhgregg, Inc. (NYSE: HGG): Three Months Ended hhgregg, Inc. (“hhgregg” or the “Company”) today reported net loss of $10.4 million, or $0.37 per diluted share, for the three month period ended September 30, 2014, compared with net income of $3.7 million, or $0.12 per diluted share, for the comparable prior year period.
Sign-up for hhgregg Announces Second Fiscal Quarter Operating Results investment picks
American Tower Corporation (NYSE:AMT) today reported financial results for the quarter ended September 30, 2014.
Sign-up for American Tower Corporation Reports Third Quarter 2014 Financial Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G024985-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/10/29/11G024985/amarin-logo-1068694627179.jpg BEDMINSTER, NJ and DUBLIN, IRELAND--(Marketwired - October 30, 2014) - Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to discuss the company's third quarter 2014 financial results and provide an operational update on Thursday, November 6, at 4:30 p.m. ET.
Sign-up for Amarin to Report Third Quarter 2014 Results and Host Conference Call on November 6, 2014 investment picks
STAMFORD, Conn., Oct.
Sign-up for Loxo Oncology to Present Pre-Clinical Data on LOXO-101 at Upcoming EORTC-NCI-AACR Symposium investment picks
Steve Madden (Nasdaq:SHOO), a leading designer and marketer of fashion footwear and accessories for women, men and children, today announced financial results for the third quarter ended September 30, 2014.
Sign-up for Steve Madden Announces Third Quarter 2014 Results investment picks
Radian Group Inc. (NYSE: RDN) today reported net income for the quarter ended September 30, 2014, of $153.6 million, or $0.67 per diluted share.
Sign-up for Radian Reports Third Quarter 2014 Financial Results investment picks
NEW YORK, Oct.
Sign-up for Liquid Holdings Group Reports Third Quarter 2014 Results investment picks
Delivered commercial and carrier revenue growth of 4.7% year-over-year Continued strong growth in Metro Ethernet sales with an increase of 14.0% year-over-year Raised $200.0 million in 6.5% unsecured senior notes due 2022 Purchased $46.8 million of our $300.0 million unsecured notes due 2020 resulting in over $2.0 million of annual interest savings Closed on the acquisition of Enventis Corporation on October 16 th MATTOON, Ill., Oct.
Sign-up for Consolidated Communications Reports Third Quarter 2014 Results investment picks
- Non-GAAP(1) operating earnings increased 6 percent to $566 million - Non-GAAP diluted earnings per share (EPS) from continuing operations decreased 9 percent to $1.00 - Prior year first quarter included an $0.18 benefit related to tax settlements; excluding this impact, non-GAAP diluted EPS increased 9 percent DUBLIN, Ohio , Oct.
Sign-up for Cardinal Health Reports Fiscal 2015 First-Quarter Results investment picks
AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2014 fourth quarter ended September 30, 2014, adjusted diluted earnings per share from continuing operations increased 35.8 percent to $1.10. Revenue increased 29.1 percent to $31.6 billion in the quarter.
Sign-up for AmerisourceBergen Reports Fourth Quarter and Fiscal Year 2014 Results investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0976041001&sourceType=1 http://www.ccnmatthews.com/logos/20110428-banner.gif PERTH, AUSTRALIA --
Sign-up for Bannerman Resources Limited Quarterly Activities Report For the Period Ended 30 September 2014 investment picks
ConocoPhillips (NYSE:COP) today reported third-quarter 2014 earnings of $2.7 billion, or $2.17 per share, compared with third-quarter 2013 earnings of $2.5 billion, or $2.00 per share.
Sign-up for ConocoPhillips Reports Third-Quarter 2014 Results; Delivering Production and Margin Growth investment picks
Third Quarter Highlights: Revenue of $95.9 million, flat compared to the prior year Income from continuing operations of $1.3 million; as adjusted income from continuing operations of $4.7 million Earnings per share from continuing operations of $0.04; as adjusted earnings per share from continuing operations of $0.13 On track to complete the previously announced definitive agreement to sell its OEM Solutions business and concurrently transfer to Symmetry Medical, Inc.'s shareholders ownership in a new company holding its Symmetry Surgical business WARSAW, Ind., Oct.
Sign-up for Symmetry Medical Reports Third Quarter 2014 Financial Results investment picks
TORONTO , Oct.
Sign-up for Maple Leaf Foods Reports Results for the Third Quarter 2014 investment picks
LA JOLLA, Calif., Oct.
Sign-up for Auspex Pharmaceuticals Initiates Second Pivotal Clinical Trial for SD-809 in Tardive Dyskinesia investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: LoJack Reports Financial Results for the Third Quarter of 2014; Appoints New Chief Financial Officer to Auspex Pharmaceuticals Initiates Second Pivotal Clinical Trial for SD-809 in Tardive Dyskinesia
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent